Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Aleck H. Hercbergs"'
Autor:
Osnat Ashur-Fabian, Haim Werner, Elena Shinderman-Maman, L Baraf, Paul J. Davis, Keren Cohen, Aleck H. Hercbergs, Martin Ellis, Dan Nabriski, Orit Twito, C Weingarten
Publikováno v:
Oncogene. 35:1977-1987
Ovarian carcinoma is the fifth common cause of cancer death in women, despite advanced therapeutic approaches. αvβ3 integrin, a plasma membrane receptor, binds thyroid hormones (L-thyroxine, T4; 3,5,3'-triiodo-L-thyronine, T3) and is overexpressed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b539a2a83e9474aeae7da7449362e7ba
https://doi.org/10.1038/onc.2015.262
https://doi.org/10.1038/onc.2015.262
Publikováno v:
Cell Cycle. 10:352-357
We describe the steady-state levels and molecular and cellular repair of DNA double-strand breaks (DSBs) in tetraiodothyroacetic acid (tetrac)-treated human U87MG glioblastoma cells after x-irradiation in vitro. This study was conducted to provide a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8df4b2bb59ed5bcd05e2a5bb08ee8ac
https://doi.org/10.4161/cc.10.2.14641
https://doi.org/10.4161/cc.10.2.14641
Publikováno v:
Current Opinion in Endocrinology, Diabetes and Obesity. 17:432-436
To collect and assess clinical reports of a putative relationship between thyroid state and the biology of cancers of various types.A number of prospective case-control studies reviewed here have suggested that subclinical hyperthyroidism increases r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd70faeafa55235a3fe88427d397c02f
https://doi.org/10.1097/med.0b013e32833d9710
https://doi.org/10.1097/med.0b013e32833d9710
Autor:
Gennadi V. Glinsky, Lawrence Lansing, Alexandre Bridoux, Paul J. Davis, Evgeny Dyskin, Hung Yun Lin, Murat Yalcin, Dhruba J. Bharali, Shaker A. Mousa, Shaymaa S Mousa, Aleck H. Hercbergs, J. Ma, Faith B. Davis, Anna B. Glinskii
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 95:1972-1980
Context: Tetraiodothyroacetic acid (tetrac) blocks angiogenic and tumor cell proliferation actions of thyroid hormone initiated at the cell surface hormone receptor on integrin αvβ3. Tetrac also inhibits angiogenesis initiated by vascular endotheli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d26513129a0faa8bf51bfa1abba9cd
https://doi.org/10.1210/jc.2009-1926
https://doi.org/10.1210/jc.2009-1926
Autor:
Mary K. Luidens, Mingzeng Sun, Aleck H. Hercbergs, Faith B. Davis, Gennadi V. Glinsky, Shaker A. Mousa, Heng Yuan Tang, Anna B. Glinskii, Hung Yun Lin, Paul J. Davis
Publikováno v:
Cell Cycle. 8:3562-3570
Tetraiodothyroacetic acid (tetrac) inhibits the cellular actions of thyroid hormone initiated at the hormone receptor on plasma membrane integrin alphavbeta3. Via interaction with the integrin, tetrac is also capable of inhibiting the angiogenic effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48dd71f8d6df4ae89eefcbaa7d0a5dea
https://doi.org/10.4161/cc.8.21.9963
https://doi.org/10.4161/cc.8.21.9963
Publikováno v:
Cell Cycle. 8:2586-2591
We studied effects of tetrac (tetraiodothyroacetic acid) on survival of GL261, a murine brain tumor cell line, following single doses of 250 kVp x-rays and on repair of damage (sublethal and potentially lethal damage repair; SLDR, PLDR) in both expon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836086eb76309be6e3cef1b0ccba2c5c
https://doi.org/10.4161/cc.8.16.9328
https://doi.org/10.4161/cc.8.16.9328
Publikováno v:
Chemotherapy. 58(3)
Background: The objective of this study was to evaluate if hypothyroidism developing during sunitib therapy in patients with metastatic renal cell carcinoma (mRCC) is associated with a better outcome. Methods: Thirty-one consecutive patients with cle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5519fa504744ed413fb766675580f3f
https://pubmed.ncbi.nlm.nih.gov/22759787
https://pubmed.ncbi.nlm.nih.gov/22759787
Autor:
Hung Yun Lin, Shaker A. Mousa, Paul J. Davis, Faith B. Davis, Heng-Yuan Tang, Aleck H. Hercbergs, Mary K. Luidens
Publikováno v:
Cell cycle (Georgetown, Tex.). 8(12)
Constitutively expressed cyclooxygenase-2 (COX-2) is a marker of tumor cell aggressiveness. Inducible COX-2 has also been described in cancer cells and localizes in the cancer cell nucleus, where formation of a complex of mitogen-activated protein ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bddcd18c2bcc9553f063ec256ffc222
https://pubmed.ncbi.nlm.nih.gov/19440051
https://pubmed.ncbi.nlm.nih.gov/19440051